We are pleased to work closely with Croda. I have personally inspected their UK plant, and it is clear to me that they are a first rate manufacturer with extremely good quality control, high standards, and drug-approval status. With Croda’s history as the developer of
Lake Forest, IL (Vocus) July 29, 2008
NourishLife announced today that they have partnered with Croda to create a nutritional solution to treat apraxia. Utilizing pharmaceutical grade omega-3 oil produced at Croda’s Active Pharmaceutical Ingredient certified UK facility, the final formulation will be based upon the Therapeutic Treatment of Apraxia patent recently licensed to NourishLife by Children’s Hospital & Research Center Oakland.
Apraxia is a neurological disorder characterized by the inability to perform purposeful motor movements, despite having the desire and physical ability to perform the movements. Verbal apraxia affects the ability to produce normal sounds needed for speech. Experts believe the number of cases is increasing in this previously rare condition. It is estimated that of 50% of autistic children have verbal apraxia. Not all children with verbal apraxia have autism.
According to David Shannon, Sales Director Health Care Croda: “We are pleased to have the opportunity to work closely with NourishLife in the supply of our purified and concentrated omega-3 product for their omega-3/antioxidant formulation for apraxia. This oil is the finest in the world, manufactured under strict quality-control procedures at our pharmaceutical-certified facility in the UK, and branded under PureMax.™ We are excited to be part of this venture and look forward to helping families through this remarkable product.”
Roy Bingham, co-founder of NourishLife states: “We are pleased to work closely with Croda. I have personally inspected their UK plant, and it is clear to me that they are a first rate manufacturer with extremely good quality control, high standards, and drug-approval status. With Croda’s history as the developer of “Lorenzo’s Oil”, they have again demonstrated great technical prowess and innovative skills.”
Bingham continues: “The anecdotal evidence reported by a large number of parents is encouraging. Of course, we cannot expect this formulation to help every child. But it appears that a significant percentage of those being supplemented with an omega-3/antioxidant cocktail are experiencing positive results." Those interested in learning more can visit speechtrial.com.
The apraxia patented treatment formulation was developed by Dr. Claudia R. Morris, MD, a published researcher, pediatric emergency medicine physician, and inventor of the nutritional apraxia cocktail. Dr. Morris states: “We have promising observations of improved speech and coordination from hundreds of parents of children with verbal apraxia when consuming my omega-3/antioxidant-based formulation. This warrants validation through controlled clinical trials, and I have designed a protocol for an interventional trial that will use my patented formulation produced by NourishLife in partnership with Croda."
Concluded Bingham: “I am pleased that NourishLife has the opportunity to make this product a reality. By working with Croda, the developer of Lorenzo’s Oil, I know we have one of the world’s leading specialty lipids experts on our team."
NourishLife intends to contribute to a major improvement in health and wellness by addressing nutritional deficiencies. Founded by nutrition industry veterans, the firm employs expert scientists and nutritionists passionate about health. The PharmaOmega division of NourishLife is becoming the web's premier source of omega-3 information, research and news.
The firm holds an exclusive license to a patented nutritional formulation designed as a therapeutic treatment of apraxia. Preliminary anecdotal evidence shows promise with reports of benefits that include speech, imitation, coordination, eye contact, behavior and sensory issues. More information can be found at speechtrial.com
NourishLife is a privately held business located outside of Chicago.
Croda Health Care is a key marketing division of Croda International Plc, a U.K.-based manufacturer and world-wide supplier to the Personal Care, Home Care and Functional Specialties, Health Care, and Manufacturing Industries. Providing naturally-derived, high quality actives and excipients for pharmaceutical, nutritional and animal health markets, the Health Care division focuses on delivering condition and application-specific solutions to meet the stringent technical, quality and market requirements of these industries. The company's extensive range of health care ingredients includes essential fatty acids, high purity lipids, drug delivery systems and protein derivatives. Globally Croda International Plc achieved worldwide sales of just over £886m (eq. $1.8 billion). The group employs over 4000 people worldwide, with an extensive sales and distribution network covering more than 60 countries.